Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types

por van der Kooij, Monique K., Speetjens, Frank M., van der Burg, Sjoerd H., Kapiteijn, Ellen
Publicado 2019

Application of Electronic Health Record Text Mining: Real-World Tolerability, Safety, and Efficacy of Adjuvant Melanoma Treatments

por van Laar, Sylvia A., Kapiteijn, Ellen, Gombert-Handoko, Kim B., Guchelaar, Henk-Jan, Zwaveling, Juliette
Publicado 2022

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer

por van Holstein, Yara, Kapiteijn, Ellen, Bastiaannet, Esther, van den Bos, Frederiek, Portielje, Johanneke, de Glas, Nienke A.
Publicado 2019

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review

por van Opijnen, Mark P., Dirven, Linda, Coremans, Ida E.M., Taphoorn, Martin J.B., Kapiteijn, Ellen H.W.
Publicado 2019

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

por Michels, Renée E., Arteaga, Carlos H., Peters, Michel L., Kapiteijn, Ellen, Van Herpen, Carla M. L., Krol, Marieke
Publicado 2022

Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies

por Burgmans, Mark C., de Leede, Eleonora M., Martini, Christian H., Kapiteijn, Ellen, Vahrmeijer, Alexander L., van Erkel, Arian R.
Publicado 2015

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer

por Aydemirli, Mehtap Derya, Corver, Willem, Beuk, Ruben, Roepman, Paul, Solleveld-Westerink, Nienke, van Wezel, Tom, Kapiteijn, Ellen, Morreau, Hans
Publicado 2019

(Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challenges

por Schneider, Tatiana C., Kapiteijn, Ellen, van Wezel, Tom, Smit, Jan W. A., van der Hoeven, Jacobus J. M., Morreau, Hans
Publicado 2016

Targeting EML4-ALK gene fusion variant 3 in thyroid cancer

por Aydemirli, Mehtap Derya, van Eendenburg, Jaap D H, van Wezel, Tom, Oosting, Jan, Corver, Willem E, Kapiteijn, Ellen, Morreau, Hans
Publicado 2021

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants

por Spagnolo, Francesco, Dalmasso, Bruna, Tanda, Enrica, Potrony, Miriam, Puig, Susana, van Doorn, Remco, Kapiteijn, Ellen, Queirolo, Paola, Helgadottir, Hildur, Ghiorzo, Paola
Publicado 2021

Nanocarriers as a Tool for the Treatment of Colorectal Cancer

por C. de S. L. Oliveira, Ana Luiza, Schomann, Timo, de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen, Cruz, Luis J., de Araújo Junior, Raimundo Fernandes
Publicado 2021

A Semi-Physiological Population Model to Quantify the Effect of Hematocrit on Everolimus Pharmacokinetics and Pharmacodynamics in Cancer Patients

por van Erp, Nielka P., van Herpen, Carla M., de Wit, Djoeke, Willemsen, Annelieke, Burger, David M., Huitema, Alwin D. R., Kapiteijn, Ellen, ter Heine, Rob
Publicado 2016

A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma

por Bauer, Sebastian, Larkin, James, Hodi, F. Stephen, Stephen, Frank, Kapiteijn, Ellen H. W., Schwartz, Gary K., Calvo, Emilano, Yerramilli-Rao, Padmaja, Piperno-Neumann, Sophie, Carvajal, Richard D.
Publicado 2023

Time Trends in Treatment Strategies and Survival of Older versus Younger Patients with Synchronous Metastasised Melanoma—A Population-Based Study in the Netherlands Cancer Registry...

por van der Ziel, Daisy, Derks, Marloes G. M., Kapiteijn, Ellen, Bastiaannet, Esther, Louwman, Marieke, van den Bos, Frederiek, Mooijaart, Simon P., Portielje, Johanneke E. A., de Glas, Nienke A.
Publicado 2022

Trends in Incidence and Survival of 1496 Patients with Mucosal Melanoma in The Netherlands (1990–2019)

por Boer, Florine L., Ho, Vincent K. Y., Louwman, Marieke W. J., Schrader, Anne M. R., Zuur, Charlotte L., Blank, Christian U., van Poelgeest, Mariette I. E., Kapiteijn, Ellen H. W.
Publicado 2023

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations

por Helgadottir, Hildur, Ghiorzo, Paola, van Doorn, Remco, Puig, Susana, Levin, Max, Kefford, Richard, Lauss, Martin, Queirolo, Paola, Pastorino, Lorenza, Kapiteijn, Ellen, Potrony, Miriam, Carrera, Cristina, Olsson, Håkan, Höiom, Veronica, Jönsson, Göran
Publicado 2020

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial

por Dotinga, Maaike, Vriens, Dennis, van Velden, Floris H. P., Stam, Mette K., Heemskerk, Jan W. T., Dibbets-Schneider, Petra, Pool, Martin, Rietbergen, Daphne D. D., de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen
Publicado 2022

Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion wit...

por de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Publicado 2017

Erratum to: Prospective Clinical and Pharmacological Evaluation of the Delcath System’s Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic P...

por de Leede, Eleonora M., Burgmans, Mark C., Meijer, T. Susanna, Martini, Christian H., Tijl, Fred G. J., Vuyk, Jaap, van Erkel, Arian R., van der Velde, Cornelis J. H., Kapiteijn, Ellen, Vahrmeijer, Alexander L.
Publicado 2017

Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltrat...

por Meijer, T. Susanna, Burgmans, Mark C., Fiocco, Marta, de Geus-Oei, Lioe-Fee, Kapiteijn, Ellen, de Leede, Eleonora M., Martini, Christian H., van der Meer, Rutger W., Tijl, Fred G. J., Vahrmeijer, Alexander L.
Publicado 2019